Skip to main content

About

Aims and scope

Epigenetics & Chromatin is a peer-reviewed, open access journal that publishes research, and reviews, providing novel insights into epigenetic inheritance and chromatin-based interactions. The journal aims to understand how gene and chromosomal elements are regulated and their activities maintained during processes such as cell division, differentiation and environmental alteration.

Epigenetic research is concerned with heritable changes that do not change DNA sequence, but rather involve stable modifications of chromatin, DNA or protein conformation, and includes research on non-coding RNAs, nuclear organization and chromatin interactions. Epigenetics is a broad area of research that is important for understanding the basic processes of cellular life, and as such has implications for a wide range of disciplines. The field encompasses studies that use model systems to discover and investigate epigenetic mechanisms and studies of human development with an emphasis on epigenetic mechanisms or chromatin organization.

Epigenetics & Chromatin fulfills the need for a journal that reflects the breadth of epigenetic research. Topics include, but are not limited to, gene silencing and imprinting, nuclear reprogramming, nucleosome modification, remodeling and dynamics, DNA methylation, non-coding RNAs, chromosomal maintenance elements, dosage compensation and nuclear organization. Approaches that apply cutting-edge technologies to problems in the field are especially welcome.

Why publish your article in Epigenetics & Chromatin?

• Ranked in the top quartile of genetics and heredity journals worldwide, we publish high quality research and expert reviews providing novel insights into epigenetic inheritance and chromatin-based interactions.
• Our internationally renowned Editors-in-Chief are supported by an expert Editorial Board, and we provide a rigorous and swift process averaging 35 days from submission to first decision.
• Open access publication ensures that your article can be easily discovered, accessed, used, and shared, maximising your impact and acting as a springboard for further discovery.
• We provide high levels of author satisfaction, with 96% of our published authors reporting that they would definitely or probably publish with us again.

Open access

All articles published by Epigenetics & Chromatin are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Epigenetics & Chromatin you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article processing charges (APC)

Authors who publish open access in Epigenetics & Chromatin are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £2290.00/$3090.00/€2590.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

Indexing services

All articles published in Epigenetics & Chromatin are included in:

  • Biological Abstracts
  • CAS
  • Citebase
  • DOAJ
  • Embase
  • EmBiology
  • MEDLINE
  • OAIster
  • PubMed
  • PubMed Central
  • Science Citation Index Expanded
  • Scopus
  • SOCOLAR
  • Zetoc

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

Epigenetics & Chromatin has an Impact Factor of 3.9 (2022) .

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.



Epigenetics & Chromatin operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous.

The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

All manuscripts are reviewed by internationally recognized experts in the field, selected in part from our Editorial Board. Reviews are usually returned within 21 days, and the suitability of a manuscript for publication is assessed solely on criteria of scientific excellence. First and final decisions are made by the Editors-in-Chief.

Epigenetics & Chromatin considers the following types of article: Research, Methodology, and Review. For more specific information, please take a look at our Submission Guidelines.

Editorial policies

All manuscripts submitted to Epigenetics & Chromatin should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Epigenetics & Chromatin

Articles in Epigenetics & Chromatin  should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Epigenetics & Chromatin [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Epigenetics & Chromatin 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies.

Benefits of publishing with BMC

High visibility

Epigenetics & Chromatin's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience. 

Speed of publication

Epigenetics & Chromatin offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Epigenetics & Chromatin gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Epigenetics & Chromatin are included in article alerts and regular email updates. Some may be highlighted on Epigenetics & Chromatin’s pages and on the BMC homepage.

In addition, articles published in Epigenetics & Chromatin may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Epigenetics & Chromatin. A list of articles recently press-released by journals published by BMC is available here.

Copyright

As an author of an article published in Epigenetics & Chromatin you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.

Annual Journal Metrics

  • 2022 Citation Impact
    3.9 - 2-year Impact Factor
    5.1 - 5-year Impact Factor
    1.097 - SNIP (Source Normalized Impact per Paper)
    2.586 - SJR (SCImago Journal Rank)

    2023 Speed
    2 days submission to first editorial decision for all manuscripts (Median)
    76 days submission to accept (Median)

    2023 Usage 
    658,550 downloads
    307 Altmetric mentions